亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

23 Bowel Urgency and Fatigue in the Real-World are Correlated With Patient Reported Outcomes and Clinical Endpoints in Crohn’s Disease

医学 疾病 患者报告的结果 重症监护医学 临床终点 物理疗法 梅德林 内科学 疾病严重程度 病人登记处 临床试验 儿科
作者
Marla Dubinsky,James D. Lewis,David T. Rubin,Wai Man Maria Chan,Aisha Vadhariya,Xian Zhou,Deborah L. Fisher,Baojin Zhu
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:120 (12S): S6-S7 被引量:1
标识
DOI:10.14309/01.ajg.0001172516.52630.e3
摘要

Background: Crohn’s disease activity index [CDAI] and simple endoscopic score for Crohn’s disease [SES-CD] are commonly used measures to assess disease activity in Crohn’s disease (CD). However, these measures may not fully reflect patient experience. Patient-reported outcomes (PROs) provide patient-centric insights about their symptoms, burden, and quality of life. This analysis explores the correlation between PROs, and PROs with clinical/endoscopic responses in patients with CD. Methods: This retrospective analysis used real-world data from the US-based registry, a multicenter Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Adults (≥18 years) diagnosed with CD were enrolled between January 2016 and July 2024. Assessments within 30 days of enrollment included sCDAI (short CDAI), SES-CD, and PROs (abdominal pain [AP], stool frequency [SF], general well-being, bowel urgency [BU] and fatigue) captured via electronic case report forms. Spearman correlation coefficients were used to assess correlations between PROs and clinical and endoscopic indices, categorized as strong (0.70–0.89), moderate (0.40–0.69), weak (0.10–0.39), and negligible (0.0–0.09). Results: Of 3435 patients identified at enrollment, mean (SD) age was 41.0 (14.42) years; 57% were female. Mean (SD) disease duration was 14.9 (11.49) years, and 67% were receiving advanced therapy. Mean (SD) sCDAI score was 151.3 (92.62), clinical remission [sCDAI <150]: 61% [n = 1916], mild disease [sCDAI: 150–219]: 20% [n = 636], moderate [sCDAI: 220–450]: 18% [n = 577], severe [sCDAI >450]: 1% [n = 38]. Mean SES-CD score was 3.5 (5.88). For AP (n = 3310), patients reported no symptoms: 47%, mild: 33%, moderate: 16% and severe AP: 5%. Mean (SD, n = 2468) SF reported was 2.2 (2.91). Responses to the general well-being (n = 3308) question were, being generally well: 57%, slightly under par: 29% and poor, very poor, or terrible: 14%. Of 3306 patients responding to BU questions, 31% reported having no BU, 32% reported mild, 17% moderate, and 15% moderately-severe or severe BU. Among 1461 patients, 51% reported experiencing fatigue. The correlation of BU was moderate with sCDAI (r = 0.51), AP (r = 0.40), SF (r = 0.47) and general well-being (r = 0.42); weak with fatigue (r = 0.31) and negligible with SES-CD (r = 0.09). Fatigue correlated moderately with sCDAI (r = 0.48), AP (r = 0.41), general well-being (r = 0.45); weakly with SF (r = 0.32) and SES-CD (r = 0.11). As components of sCDAI, AP (r = 0.74) and general well-being (r = 0.78) correlated strongly; SF (r = 0.62) correlated moderately with sCDAI. Correlation of SES-CD was weak with AP (r = 0.13), general well-being (r = 0.15) and SF (r = 0.16). General well-being correlated moderately with AP (r = 0.54), and weakly with SF (r = 0.34). Conclusions: Most patients with CD enrolled in SPARC IBD exhibit mildly active disease based on their clinical, endoscopic and patient-reported symptomatic endpoints. However, the observed correlations align with results seen in populations with moderately to severely active CD. Notably, BU and fatigue, which are important symptoms in CD, consistently demonstrated a higher correlation with PROs and sCDAI than with SES-CD. These findings support the use of BU and fatigue as independent, patient-centered measures at the point of care.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Raye发布了新的文献求助10
1秒前
齐7发布了新的文献求助10
3秒前
5秒前
6秒前
难过洙完成签到,获得积分10
7秒前
10秒前
12秒前
温暖大米发布了新的文献求助10
16秒前
Raye完成签到 ,获得积分10
20秒前
汉堡包的应助被zbs采纳,获得10
20秒前
21秒前
30秒前
30秒前
慈祥的网络完成签到,获得积分10
31秒前
郭泓嵩完成签到,获得积分10
32秒前
35秒前
Xieyusen完成签到,获得积分10
36秒前
39秒前
39秒前
40秒前
41秒前
42秒前
榨菜完成签到 ,获得积分10
44秒前
44秒前
ldxghh发布了新的文献求助10
45秒前
46秒前
dakaein发布了新的文献求助10
47秒前
大反应釜完成签到,获得积分10
48秒前
49秒前
Lia_Yee发布了新的文献求助10
49秒前
cam发布了新的文献求助10
51秒前
zbs发布了新的文献求助10
52秒前
害羞白猫完成签到 ,获得积分10
55秒前
cam完成签到,获得积分20
57秒前
Kepler完成签到,获得积分10
1分钟前
星辰大海的应助被科研通管家采纳,获得10
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172940
求助须知:如何正确求助?哪些是违规求助? 9565447
关于积分的说明 21779943
捐赠科研通 7764803
什么是DOI,文献DOI怎么找? 3431480
关于科研通互助平台的介绍 2555495
邀请新用户注册赠送积分活动 2476544